Anti-Ri antibodies associated with short-term memory deficits and a mature cystic teratoma of the ovary
Open Access
- 10 November 2004
- journal article
- Published by Springer Nature in International Seminars in Surgical Oncology
- Vol. 1 (1) , 11
- https://doi.org/10.1186/1477-7800-1-11
Abstract
Background: The IgG autoantibody ANNA-2 (anti-Ri) is a type 2 antineuronal antibody that has been found to bind to highly conserved and widely distributed adult brain proteins encoded by the Nova-1 and Nova-2 genes. Anti-Ri antibodies are typically detected in the serum and cerebrospinal fluids of patients with neurological disorders such as opsoclonus/myoclonus and cerebellar ataxia and in association with gynecologic and breast malignancies. Case Presentation: This report describes an unusual example of a 33-year-old female patient who developed short-term memory deficits over a 3-month period. An extensive neurological work-up, including a panel of paraneoplastic markers was negative with the exception of a high titer serum Anti-Ri (1:15,3600). A large left ovarian mass was palpated, surgically resected and eventually diagnosed as a mature cystic teratoma. Post-operatively, memory deficits had disappeared within 1 month and serum Anti-Ri titers had decreased significantly to 1:256. An extensive diagnostic work-up for other malignancies was negative. Conclusion: Although, Anti-Ri antibodies are typically associated with malignancies, this case illustrates the potential association between benign tumors and this autoantibody.Keywords
This publication has 10 references indexed in Scilit:
- Paraneoplastic Neurologic DisordersArchives of Neurology, 2004
- Paraneoplastic Syndromes Involving the Nervous SystemNew England Journal of Medicine, 2003
- Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompanimentsAnnals of Neurology, 2003
- Paraneoplastic neurologic syndromesNeurologic Clinics, 2003
- Phenotypic variants of autoimmune peripheral nerve hyperexcitabilityBrain, 2002
- The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementiaProceedings of the National Academy of Sciences, 1998
- Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neuronsNeuroscience Letters, 1993
- Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancerAnnals of Neurology, 1991
- An antineuronal autoantibody in paraneoplastic opsoclonusAnnals of Neurology, 1988